2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell LymphomaRelapsed and/or Refractory B-cell LymphomaRecruitingPhase 1 / Phase 22026-09-25NCT04989803
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell LymphomaHigh-risk Large B-cell Lymphoma (LBCL)Active, not recruitingPhase 32026-04-15NCT05605899